Do you still think ImmunityBio Inc (NASDAQ:IBRX) is worth a look?
In yesterday’s Wall Street session, ImmunityBio Inc (NASDAQ:IBRX) shares traded at $6.06, up 1.68% from the previous session. IBRX stock price is now 22.63% away from the 50-day moving average and 83.73% away from the 200-day moving average. The market capitalization of the company currently stands at $4.08B. With the price target reduced from $10 […]
There’s Something Awry at ImmunityBio Inc (NASDAQ:IBRX) Since Share Price Gets Ahead of Fundamentals
ImmunityBio Inc (NASDAQ:IBRX) shares traded -1.58% lower at $5.62 on Wall Street last session. IBRX stock price is now 19.94% away from the 50-day moving average and 74.54% away from the 200-day moving average. The market capitalization of the company currently stands at $3.79B. With the price target reduced from $10 to $4, Piper Sandler […]
When is the right time to cash out of ImmunityBio Inc [IBRX] stock?
In yesterday’s Wall Street session, ImmunityBio Inc (NASDAQ:IBRX) shares traded at $6.17, up 3.01% from the previous session. IBRX stock price is now 40.93% away from the 50-day moving average and 98.88% away from the 200-day moving average. The market capitalization of the company currently stands at $4.16B. With the price target reduced from $10 […]
How should investors evaluate ImmunityBio Inc (NASDAQ:IBRX)?
In yesterday’s Wall Street session, ImmunityBio Inc (NASDAQ:IBRX) shares traded at $3.93, up 5.65% from the previous session. As of this writing, 1 analysts cover ImmunityBio Inc (NASDAQ:IBRX). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $4.00 and a low of […]
There’s Something Awry at ImmunityBio Inc (NASDAQ:IBRX) Since Share Price Gets Ahead of Fundamentals
ImmunityBio Inc (NASDAQ:IBRX) shares traded -7.54% lower at $3.68 on Wall Street last session. In accordance with the data, 1 analysts cover ImmunityBio Inc (NASDAQ:IBRX). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $4.00 and a low of $4.00, we find […]
Before You Invest In ImmunityBio Inc (NASDAQ:IBRX), Consider This Metric
In yesterday’s Wall Street session, ImmunityBio Inc (NASDAQ:IBRX) shares traded at $4.19, up 12.03% from the previous session. As of this writing, 1 analysts cover ImmunityBio Inc (NASDAQ:IBRX). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $4.00 and a low of […]
The shares of ImmunityBio Inc (IBRX) have recorded the market capitalization of 2.08B
ImmunityBio Inc (NASDAQ:IBRX) shares traded 9.31% higher at $3.11 on Wall Street last session. In accordance with the data, 1 analysts cover ImmunityBio Inc (NASDAQ:IBRX). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $5.00 and a low of $5.00, we find […]
Can ImmunityBio Inc (IBRX) stock recover despite sales dropping?
In yesterday’s Wall Street session, ImmunityBio Inc (NASDAQ:IBRX) shares traded at $3.63, up 0.83% from the previous session. 1 analysts cover ImmunityBio Inc (NASDAQ:IBRX), according to research data. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $5.00 and a low of […]
An overview of ImmunityBio Inc’s (IBRX) institutional holdings
The price of ImmunityBio Inc (NASDAQ:IBRX) shares last traded on Wall Street rose 24.19% to $3.08. Based on available information, 1 analysts follow ImmunityBio Inc (NASDAQ:IBRX). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $5.00 and a low of $5.00, we […]
The shares of ImmunityBio Inc (IBRX) have recorded the market capitalization of 1.20B
The stock of ImmunityBio Inc (NASDAQ:IBRX) last traded at $1.80, up 25.87% from the previous session. IBRX stock price is now 14.97% away from the 50-day moving average and -28.43% away from the 200-day moving average. The market capitalization of the company currently stands at $1.20B. With the price target reduced from $10 to $4, […]